HT also suppressed angiogenesis, tumor growth, and induced apoptosis and cell cycle arrest by suppressing the activation of NF-κB and Akt pathways both in human hepatocellular carcinoma cells (HCC) in vitro and in an orthotopic model of human HCC in vivo [102]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.